[Percutaneous radiotherapy of cervical cancer].
Whereas the local effect of radiotherapy in the postoperative treatment of uterine cervix cancer developing lymphogenic metastases may be regarded as clearly demonstrated, there is no evidence of its effect on the survival of patients. A definite answer to this question is only possible on the basis of prospective studies. In primary radiotherapy, more importance than in former days is given to percutaneous irradiation which allows a more homogeneous dose to the small pelvis. According to the present state of knowledge it is not justified to do without contact therapy except in cases of a very advanced disease.
D001761:Bleomycin / Q000031:analogs & derivatives; D003037:Cobalt Radioisotopes / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*
D003037:Cobalt Radioisotopes; C030187:cobalt bleomycin; D001761:Bleomycin
Zur perkutanen Strahlentherapie des Zervixkarzinoms.